For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $1.92 in the prior trading day, Lisata Therapeutics Inc (NASDAQ: LSTA) closed at $1.86, down -3.12%. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 50297.0 shares were traded. LSTA stock price reached its highest trading level at $2.015 during the session, while it also had its lowest trading level at $1.835.
Ratios:
Our goal is to gain a better understanding of LSTA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.72 and its Current Ratio is at 4.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LSTA now has a Market Capitalization of 16406565 and an Enterprise Value of -2845436. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.34 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at -2.659 whereas that against EBITDA is 0.143.
Stock Price History:
The Beta on a monthly basis for LSTA is 1.11, which has changed by -0.46218485 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, LSTA has reached a high of $4.20, while it has fallen to a 52-week low of $1.81. The 50-Day Moving Average of the stock is -13.72%, while the 200-Day Moving Average is calculated to be -21.75%.
Shares Statistics:
The stock has traded on average 69.64K shares per day over the past 3-months and 32100 shares per day over the last 10 days, according to various share statistics. A total of 8.76M shares are outstanding, with a floating share count of 7.32M. Insiders hold about 16.97% of the company’s shares, while institutions hold 8.38% stake in the company. Shares short for LSTA as of 1765756800 were 15440 with a Short Ratio of 0.22, compared to 1763078400 on 21397. Therefore, it implies a Short% of Shares Outstanding of 15440 and a Short% of Float of 0.21.
Earnings Estimates
The dynamic stock of Lisata Therapeutics Inc (LSTA) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating. Analysts are recommending an EPS of between -$2.09 and -$2.19 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$1.02, with 2.0 analysts recommending between -$0.96 and -$1.09.
